Small molecule screening for HtrA2 activation to mitigate neurodegenerative diseases
This research focuses on screening small molecule compounds to activate HtrA2, a mitochondrial protease, potentially restoring mitochondrial function and mitigating neurodegenerative diseases by blocking the PDZ domain.